These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 7538563
1. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Björklund A. J Neurosci; 1995 May; 15(5 Pt 1):3548-61. PubMed ID: 7538563 [Abstract] [Full Text] [Related]
2. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery. Nikkhah G, Cunningham MG, McKay R, Björklund A. J Neurosci; 1995 May; 15(5 Pt 1):3562-70. PubMed ID: 7751930 [Abstract] [Full Text] [Related]
3. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. Wictorin K, Brundin P, Sauer H, Lindvall O, Björklund A. J Comp Neurol; 1992 Sep 22; 323(4):475-94. PubMed ID: 1358925 [Abstract] [Full Text] [Related]
4. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Cenci MA, Kalén P, Mandel RJ, Wictorin K, Björklund A. Neuroscience; 1992 Sep 22; 46(4):943-57. PubMed ID: 1347413 [Abstract] [Full Text] [Related]
5. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Bentlage C, Nikkhah G, Cunningham MG, Björklund A. Exp Neurol; 1999 Sep 22; 159(1):177-90. PubMed ID: 10486186 [Abstract] [Full Text] [Related]
6. Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats. Chiang Y, Morales M, Zhou FC, Borlongan C, Hoffer BJ, Wang Y. Brain Res; 2001 Jan 19; 889(1-2):200-7. PubMed ID: 11166704 [Abstract] [Full Text] [Related]
7. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. Mendez I, Sadi D, Hong M. J Neurosci; 1996 Nov 15; 16(22):7216-27. PubMed ID: 8929430 [Abstract] [Full Text] [Related]
8. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting. Törnqvist N, Björklund L, Strömberg I. Exp Neurol; 2001 Jun 15; 169(2):329-39. PubMed ID: 11358446 [Abstract] [Full Text] [Related]
9. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Haque NS, LeBlanc CJ, Isacson O. Cell Transplant; 1997 Jun 15; 6(3):239-48. PubMed ID: 9171157 [Abstract] [Full Text] [Related]
10. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Abrous DN, Torres EM, Dunnett SB. Neuroscience; 1993 Jun 15; 54(3):657-68. PubMed ID: 8332254 [Abstract] [Full Text] [Related]
11. Development of human fetal ventral mesencephalic grafts in rats with 6-OHDA lesions of the nigrostriatal pathway. Kondoh T, Pundt LL, Low WC. Neurosci Res; 1995 Jan 15; 21(3):223-33. PubMed ID: 7753503 [Abstract] [Full Text] [Related]
12. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents. Mandel RJ, Wictorin K, Cenci MA, Björklund A. Brain Res; 1992 Jun 26; 583(1-2):207-15. PubMed ID: 1504828 [Abstract] [Full Text] [Related]
13. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Kirik D, Rosenblad C, Björklund A. Eur J Neurosci; 2000 Nov 26; 12(11):3871-82. PubMed ID: 11069582 [Abstract] [Full Text] [Related]
14. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. Palmer MR, Granholm AC, van Horne CG, Giardina KE, Freund RK, Moorhead JW, Gerhardt GA. Brain Res; 2001 Jan 26; 890(1):86-99. PubMed ID: 11164771 [Abstract] [Full Text] [Related]
15. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Tang FI, Tien LT, Zhou FC, Hoffer BJ, Wang Y. Exp Brain Res; 1998 Apr 26; 119(3):287-96. PubMed ID: 9551829 [Abstract] [Full Text] [Related]
16. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. Nikkhah G, Bentlage C, Cunningham MG, Björklund A. J Neurosci; 1994 Jun 26; 14(6):3449-61. PubMed ID: 7911516 [Abstract] [Full Text] [Related]
17. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants. Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK. Brain Res; 1991 Feb 01; 540(1-2):145-52. PubMed ID: 1905173 [Abstract] [Full Text] [Related]
18. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Wang Y, Tien LT, Lapchak PA, Hoffer BJ. Cell Tissue Res; 1996 Nov 01; 286(2):225-33. PubMed ID: 8854891 [Abstract] [Full Text] [Related]
19. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Nikkhah G, Olsson M, Eberhard J, Bentlage C, Cunningham MG, Björklund A. Neuroscience; 1994 Nov 01; 63(1):57-72. PubMed ID: 7898661 [Abstract] [Full Text] [Related]
20. Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat. Todaka K, Ishida Y, Hashiguchi H, Nishimori T, Mitsuyama Y. Exp Neurol; 1999 Dec 01; 160(2):394-401. PubMed ID: 10619556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]